ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.837,17
0,51%
S&P 500
5.237,86
0,46%
US Dollar vs BRL
5,1363
-0,12%
Bitcoin
63.020,45
-0,05%
Brent Oil
83,965
0,02%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Brickell Biotech Inc (BBI)

  7. Brickell Biotech Inc (BBI) Notícias

BBI

Brickell Biotech (BBI)

Brickell Biotech Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BBI
DataHoraFonteTítuloCódigoCompanhia
10/05/202317:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BBIBrickell Biotech Inc
01/05/202317:44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:BBIBrickell Biotech Inc
22/02/202318:04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BBIBrickell Biotech Inc
13/02/202319:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BBIBrickell Biotech Inc
26/01/202320:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BBIBrickell Biotech Inc
14/11/202208:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BBIBrickell Biotech Inc
12/09/202207:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BBIBrickell Biotech Inc
06/09/202217:44Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:BBIBrickell Biotech Inc
02/09/202217:08Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BBIBrickell Biotech Inc
23/06/202217:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BBIBrickell Biotech Inc
22/06/202207:03Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BBIBrickell Biotech Inc
17/06/202210:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BBIBrickell Biotech Inc
07/06/202217:29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:BBIBrickell Biotech Inc
27/05/202209:59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BBIBrickell Biotech Inc
24/05/202218:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BBIBrickell Biotech Inc
15/03/202208:48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BBIBrickell Biotech Inc
28/10/202118:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BBIBrickell Biotech Inc
03/09/202109:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BBIBrickell Biotech Inc
22/07/202110:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BBIBrickell Biotech Inc
19/07/202118:27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:BBIBrickell Biotech Inc
15/03/202109:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BBIBrickell Biotech Inc
09/03/202118:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BBIBrickell Biotech Inc
22/10/202007:11Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BBIBrickell Biotech Inc
24/09/202016:47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BBIBrickell Biotech Inc
13/08/202018:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BBIBrickell Biotech Inc
03/08/202017:05GlobeNewswire Inc.Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020NASDAQ:BBIBrickell Biotech Inc
17/06/202023:00GlobeNewswire Inc.Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public OfferingNASDAQ:BBIBrickell Biotech Inc
15/06/202007:30GlobeNewswire Inc.Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Pa...NASDAQ:BBIBrickell Biotech Inc
13/05/202017:01GlobeNewswire Inc.Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:BBIBrickell Biotech Inc
04/05/202017:05GlobeNewswire Inc.Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020NASDAQ:BBIBrickell Biotech Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BBI

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
VVEO3
CM Hospitalar ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
LUPA3
LUPATECH ON
BOV
PRIO3
PETRORIO ON
BOV
UNIP6
UNIPAR PNB
BOV
TELB4
TELEBRAS PN
BOV
COGN3
COGNA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
CMIN3
CSN Mineracao S.A ON
BOV
RNEW4
RENOVA PN
BOV
SHOW3
TIME FOR FUN ON
BOV
TCSA3
TECNISA ON
BOV
LIGT3
LIGHT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados